Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments
Penumbra’s stock was up about 14% after the deal was announced Thursday morning.
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
Spencer Jakab | With ETFs, Can You Have Too Much of a Good Thing?
Post Content
Gas Turbine Supply Chain Bottlenecks Could Reshape the Generation Mix in 2030 and Beyond
Post Content
Airline miles and hotel points threatened as Trump takes aim at credit-card rules
While some experts doubt the measure will actually become reality, they thought it would disproportionately curb rewards for lower-income spenders if enacted, while high-flyers would be able to keep cashing in on rewards.
Uber’s 2025 Reality Check: 3 Shifts Investors Can’t Ignore
Post Content
Earnings live: Goldman Sachs and BlackRock profits beat, TSMC stock jumps on robust outlook
Post Content
Dividend Investor Making $10,000 a Month Shares His Top 8 Stocks, Says AI Stocks Helped Him Reach Goals – ‘Tempted To Just Go Ahead And Retire’
Post Content
Stocks making the biggest moves premarket: Taiwan Semiconductor, ASML, BlackRock and more
These are the stocks posting the largest moves in the premarket.
Here’s how much money you need to make to afford a $400,000 home
Homeownership is a key pillar of the American Dream, but exactly how much does one need to earn in terms of an income or salary to afford it?
New Supply Chain Partnerships Help Scale Efficiency and Textile Innovation
Post Content